|1.||Hurault de Ligny, Bruno: 1 article (10/2003)|
|2.||Bernaud, Corine: 1 article (10/2003)|
|3.||Moulin, Bruno: 1 article (10/2003)|
|4.||Lavaud, Sylvie: 1 article (10/2003)|
|5.||Toupance, Olivier: 1 article (10/2003)|
|6.||Chanard, Jacques: 1 article (10/2003)|
|7.||Martinez, J A: 1 article (06/2001)|
|8.||Margareto, J: 1 article (06/2001)|
|9.||Larrarte, E: 1 article (06/2001)|
|10.||Marti, A: 1 article (06/2001)|
|1.||Hypertension (High Blood Pressure)
11/01/1989 - "Renal perfusion has been shown to be preserved or improved during treatment by tertatolol in patients with arterial hypertension. "
07/01/1991 - "The antihypertensive effects of tertatolol, a new non-cardioselective beta-blocking drug, were investigated in 20 patients with mild to moderate primary arterial hypertension, in a placebo controlled double blind randomized study. "
12/01/1989 - "Additional benefits of combining beta-blockade and renal vasodilation in the treatment of mild to moderate hypertension: Tertatolol International Multicentre Study results."
01/01/1986 - "The long-term antihypertensive activity and acceptability of a new beta-blocking agent tertatolol (T) (5 mg once daily) was assessed in a 12-month (M0-M12) open study, in 110 out-patients (64 men, 46 women, mean age 53.5 +/- 1.0 years), presenting with stable placebo-resistant hypertension (HT) (95 less than or equal to diastolic blood pressure less than 130 mm Hg on 3 occasions during a 1-month placebo run-in period). "
01/01/1993 - "Beta-Blockers in the Treatment of Hypertension in the 90's: Experience with Tertatolol. "
|2.||Chronic Kidney Failure (Chronic Renal Failure)
07/01/1988 - "Tertatolol ameliorates renal function in rats with chronic renal failure."
01/01/1991 - "These results indicate that tertatolol possesses novel renal haemodynamic properties in hypertensive patients with chronic renal failure. "
01/01/1991 - "To assess the potential benefit of drug-induced renal haemodynamic changes in patients with chronic renal failure, we have evaluated the effects of the beta-blocking agent tertatolol on blood pressure, glomerular filtration rate, and renal plasma flow. "
01/01/1991 - "Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure."
11/01/1989 - "Tertatolol in chronic renal failure. "
|3.||Migraine Disorders (Migraine)
09/10/1992 - "It is therefore suggested that tertatolol may prove effective in the treatment of migraine."
09/10/1992 - "Two other beta-adrenoceptor antagonists, one (propranolol) with and one (pindolol) without antimigraine actions, were compared (doses: 0.03, 0.1, 0.3 and 1 mg/kg i.v.) with tertatolol in this animal experimental model of migraine. "
09/10/1992 - "Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol."
10/01/1989 - "In 15 previously untreated hypertensive subjects with left ventricular (LV) hypertrophy who responded favorably (supine blood pressure less than or equal to 140/90 mm Hg) to antihypertensive treatment with a nonselective beta-blocking agent, tertatolol, the effects of reversal of LV hypertrophy on systolic and diastolic function were assessed. "
|5.||Peripheral Arterial Disease
|3.||Calcium Channels (Calcium Channel)
|6.||Biological Markers (Surrogate Marker)
|9.||Pindolol (LB 46)
|1.||Transplantation (Transplant Recipients)